Dyspepsia - Dopamine.

Suspended

• Registration Number: NL-OMON22541

Brief Summary

/A

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 28 February 2024

Recruitment & Eligibility

• Status: Suspended
• Sex: Not specified
• Target Recruitment: 15

Inclusion Criteria

1. Nepean Dyspepsia Index (NDI) score >= 25;

2. >18 years of age.

Exclusion Criteria

1. Use of drugs that affect gastrointestinal motility (antidepressants, opiates, NSAID’s, calcium-blockers, nitrates);

2. use of drugs that can affect binding of the radioligand to dopamine D2 receptors (neuroleptics, dopamine D2 agonists, anti-vertigo-drugs metoclopramide, alizapride);

Study & Design

• Study Type: Interventional
• Study Design: Not specified